Business
Microbot Medical Attracts Another Leading Physician and Expands Capabilities of its Scientific Advisory Board with Addition of Dr. Ripal Gandhi
Miami-based Physician Specializes in Minimally Invasive Treatments for Peripheral Vascular Disease, Cancer, and Other Diseases HINGHAM, Mass., Sept. 19, 2022
About this update from Microbot Medical Inc.
[{"type":"text","content":"Miami-based Physician Specializes in Minimally Invasive Treatments for Peripheral Vascular Disease, Cancer, and Other Diseases HINGHAM, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), continuing its recent success of strengthening its Scientific Advisory Board with the recent recruitment of Key Opinion Leaders (KOLs), today announced that Ripal T. Gandhi, MD, FSVM, will join the Company’s robust Scientific Advisory Board (SAB). Dr. Gandhi is an interventional oncologist and a member of the Miami Cardiac & Vascular Institute and Miami Cancer Institute physician team where he specializes in minimally invasive treatments for peripheral vascular disease, cancer, and other diseases, and has a history of being an innovator in the Interventional Robotics field. “Today we announce a very exciting addition to our Scientific Advisory Board, as Dr. Gandhi is a robotic pioneer, has considerable experience with previous generations of endovascular surgical robotics, and clearly knows the challenges they present and how our LIBERTY Robotic System can address most, if not all of them,” commented Harel Gadot, CEO, President, and Chairman.” “Having completed over 100 robotic cases in the interventional space using larger bulky capital equipment, I was immediately drawn to the LIBERTY technology and the barriers it breaks down,” Commented Dr. Gandhi. “I am excited to bring my first-hand experience to help guide the Microbot team’s revolutionary approach to create the first ever fully disposable robotic system, which I believe will be central in driving robotic adoption in this space.” Dr. Ripal Gandhi is experienced in treating cancers, peripheral arterial disease (PAD), thoracic aortic aneurysms, abdominal aortic aneurysms (AAA), uterine fibroids, deep venous thrombosis, pulmonary embolism, varicoceles, and varicose veins. Dr. Gandhi is a clinical professor at the University of South Florida School of Medicine and FIU Herbert Wertheim College of Medicine, training physicians in vascular/endovascular, interventional radiology and interventional oncology techniques. While at Memorial Sloan-Kettering, he investigated hepatic embolization and other minimally invasive therapies for liver cancer and other malignancies. Dr. Gandhi received his medical degree from Northwestern University Medical School, completed surgical...